Yabao Pharmaceutical Group Co. Ltd. Class ASSE: 600351

Announcement on Obtaining Notice of Approval for Drug Clinical Trials of ZY-A002

· Issued by Yabao Pharmaceutical Group Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Obtaining Notice of Approval for Drug Clinical Trials of ZY-A002

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment